[Pregnancy and antiphospholipid antibodies]
- PMID: 18829248
- DOI: 10.1016/j.lpm.2008.08.001
[Pregnancy and antiphospholipid antibodies]
Abstract
Antiphospholipid syndrome is one of the few treatable causes of pregnancy loss, and successful pregnancy rates of 70% or more can be achieved with appropriate treatment. Pregnancy in these women is associated with increased rates of preeclampsia, placental insufficiency, and preterm delivery. Several studies indicate that heparin, usually combined with low-dose aspirin, is beneficial in this indication. Recent works underlines the role of complement activation in a murine model of antiphospholipid pregnancy loss, which should be confirmed in Human.
Similar articles
-
Current insights in obstetric antiphospholipid syndrome.Curr Opin Obstet Gynecol. 2017 Dec;29(6):397-403. doi: 10.1097/GCO.0000000000000406. Curr Opin Obstet Gynecol. 2017. PMID: 28915160 Review.
-
Antiphospholipid antibody syndrome.Obstet Gynecol Clin North Am. 2014 Mar;41(1):113-32. doi: 10.1016/j.ogc.2013.10.004. Obstet Gynecol Clin North Am. 2014. PMID: 24491987 Review.
-
A literature review on the antiphospholipid syndrome and the effect on childbearing.Midwifery. 2001 Jun;17(2):142-9. doi: 10.1054/midw.2000.0242. Midwifery. 2001. PMID: 11399135 Review.
-
Obstetric antiphospholipid syndrome: still a challenge.Lupus. 2010 Apr;19(4):457-9. doi: 10.1177/0961203309361484. Lupus. 2010. PMID: 20353988
-
Pregnancy in antiphospholipid syndrome: can we improve patient management?Isr Med Assoc J. 2014 Oct;16(10):614-5. Isr Med Assoc J. 2014. PMID: 25438445 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical